Blood transfusion rates in Baby NINJA (Nephrotoxic Injury Negated by Just-in-Time Action)—a single-center experience

Hailey W. Gavigan,Cara L. Slagle,Kelli A. Krallman,Brenda B. Poindexter,David K. Hooper,Stuart L. Goldstein

DOI: https://doi.org/10.1007/s00467-020-04917-5

2021-01-22

Pediatric Nephrology

Abstract:BackgroundPrevious studies in non-critically ill hospitalized pediatric patients have shown that daily serum creatinine monitoring for the development of nephrotoxic medication–associated acute kidney injury decreases both the rate of high nephrotoxic medication exposure and associated acute kidney injury. Attempts to spread this successful screening program have been met with concerns that daily serum creatinine monitoring in critically ill neonates with high-risk nephrotoxic medication exposure would lead to iatrogenic anemia and an increase in blood transfusion requirements.MethodsWe measured blood transfusion rates while implementing a system of daily serum creatinine monitoring in critically ill neonates at risk for high nephrotoxic medication–associated acute kidney injury.ResultsThere was no correlation between blood transfusion rates and serum creatinine monitoring rates.ConclusionsWe recommend that critically ill neonates identified as having high-risk nephrotoxic medication exposure undergo daily screening for the development of nephrotoxic medication–associated acute kidney injury.

pediatrics,urology & nephrology